Crossmark

Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States

Crossref DOI link: https://doi.org/10.1007/s12325-023-02605-y

Published Online: 2023-07-17

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Afzali, Anita https://orcid.org/0000-0002-4397-9576
Lukanova, Rina https://orcid.org/0000-0002-1414-0720
Hennessy, Fritha https://orcid.org/0000-0002-3387-5423
Kakehi, Sumie https://orcid.org/0000-0002-4398-7269
Knight, Hannah https://orcid.org/0000-0002-8379-4381
Milligan, Gary https://orcid.org/0000-0002-1427-3339
Gupte-Singh, Komal https://orcid.org/0000-0002-4886-6183
Funding

Funding for this research was provided by:

Bristol-Myers Squibb
License Information

Text and Data Mining valid from 2023-07-17

Version of Record valid from 2023-07-17
More Information

Article History

Received: 28 April 2023

Accepted: 28 June 2023

First Online: 17 July 2023